CYCN
CYCLERION THERP (CYCN)
NASDAQ
$3.27$0.00 (0.00%)
Price as of Jun 23, 2026 4:10 PM EDT
  • $13.9M
    Market Cap
  • 9.15%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
1.0M
-42.86%
1.8M
N/A
0
-100.00%
1.6M
-58.78%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
1.0M
-42.86%
1.8M
N/A
0
-100.00%
1.6M
-58.78%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-959,000
+235.31%
-286,000
-81.12%
-1.5M
-95.19%
-31.5M
-16.32%
Depreciation and Amortization Expense
N/A
N/A
0
N/A
0
-100.00%
65,000
-86.23%
Total Operating Expenses
7.0M
+25.21%
5.6M
-56.54%
13.0M
-71.84%
46.0M
-22.22%
Operating Profit
-5.0M
+37.07%
-3.6M
-71.99%
-13.0M
-70.81%
-44.4M
-19.61%
Interest Income
128,000
-38.46%
208,000
-48.00%
400,000
+33.33%
300,000
0.00%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-100,000
0.00%
Interest Income and Expense and Net
128,000
-38.46%
208,000
-48.00%
400,000
+100.00%
200,000
0.00%
Total Nonoperating Income and Expense
1.4M
+153.06%
571,000
+59.50%
358,000
+21.77%
294,000
+1,937.50%
Income before Taxes
-5.0M
+62.68%
-3.1M
-75.72%
-12.6M
-71.62%
-44.4M
-19.61%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
0
-100.00%
3.3M
N/A
N/A
N/A
Net Income
-3.5M
+15.41%
-3.1M
-41.92%
-5.3M
-111.93%
44.1M
+185.39%
Net Income from Continuing Operations Applicable to Common
-3.5M
+15.41%
-3.1M
-75.72%
-12.6M
-128.56%
44.1M
+185.39%
Basic EPS and Net Income
-1.11
-8.26%
-1.21
-46.22%
-2.25
+122.77%
-1.01
-23.48%
Diluted EPS and Net Income
-1.11
-8.26%
-1.21
-46.22%
-2.25
+122.77%
-1.01
-23.48%
Basic Weighted Average Shares
3.2M
+26.33%
2.5M
+7.70%
2.3M
-94.62%
43.5M
+11.05%
Diluted Weighted Average Shares
3.2M
+26.33%
2.5M
+7.70%
2.3M
-94.62%
43.5M
+11.05%
Balance Sheet
Cash and Cash Equivalents
3.2M
+0.25%
3.2M
-57.31%
7.6M
-43.42%
13.4M
-75.20%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.2M
+0.25%
3.2M
-57.31%
7.6M
-43.42%
13.4M
-75.20%
Total Current Assets
4.6M
+9.70%
4.2M
-47.35%
8.0M
-45.86%
14.8M
-73.28%
Accumulated Depreciation
N/A
N/A
126,000
0.00%
126,000
-94.22%
2.2M
-0.86%
Property and Plant and Equipment and Net
N/A
N/A
0
N/A
0
N/A
0
-100.00%
Total Long-Term Assets
N/A
N/A
0
N/A
0
-100.00%
2.0M
-15.21%
Total Assets
10.0M
+4.28%
9.6M
-28.41%
13.4M
-26.02%
18.1M
-69.53%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
3.5M
N/A
Total Current Liabilities
900,000
+24.14%
725,000
-65.24%
2.1M
-72.65%
7.6M
-31.20%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
900,000
+24.14%
725,000
-65.24%
2.1M
-72.65%
7.6M
-31.20%
Retained Earnings
-271.0M
+1.32%
-267.5M
+1.16%
-264.4M
+2.03%
-259.2M
+20.49%
Total Stockholders Equity
9.1M
+2.66%
8.8M
-21.60%
11.3M
+8.00%
10.5M
-78.34%
Total Shares Outstanding
3.8M
+50.09%
2.5M
+2.90%
2.5M
-94.31%
43.5M
+0.25%
Cash Flow
Cash from Operating Activities
-3.3M
-23.52%
-4.3M
-79.60%
-21.2M
-47.69%
-40.6M
+11.21%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
0
-100.00%
Cash from Investing Activities
N/A
N/A
0
-100.00%
10.4M
N/A
0
-100.00%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
3.3M
N/A
0
-100.00%
5.0M
+17,224.14%
29,000
-99.91%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-497.30%
+139.88%
-207.31%
N/A
N/A
N/A
-2,730.58%
+95.02%
Return on Assets
-36.07%
+35.40%
-26.64%
-20.39%
-33.47%
-129.37%
113.94%
+292.71%
Return on Equity
-39.34%
+29.58%
-30.36%
-37.29%
-48.42%
-132.22%
150.26%
+256.73%
Revenue Growth
-42.86%
N/A
N/A
N/A
-100.00%
+70.13%
-58.78%
-181.99%
Current Ratio
5.15
-11.63%
5.83
+51.50%
3.85
+97.96%
1.94
-61.16%
Cash Ratio
3.60
-19.24%
4.46
+22.83%
3.63
+106.85%
1.75
-63.96%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow